Changeflow GovPing Healthcare & Life Sciences Formulation for Hair Growth
Routine Notice Added Final

Formulation for Hair Growth

Email

Summary

The USPTO has published a new patent application, US20260083789A1, for a formulation designed to stimulate hair growth and improve hair quality. The formulation primarily utilizes a nitrate-enriched extract of Amaranth, along with other plant-based ingredients. The application details the method of preparation and its potential use in enhancing hair growth rate, count, and density.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a new patent application (US20260083789A1) filed with the USPTO by ARJUNA NATURAL PRIVATE LIMITED. The patent application describes a formulation for stimulating hair growth and improving hair quality, featuring a nitrate-enriched extract of Amaranth as a key ingredient. It also outlines the preparation method and claims benefits such as increased cell proliferation, wound healing potential, and enhanced hair growth rate, count, and density.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future intellectual property protection for a novel cosmetic or therapeutic formulation. Companies operating in the pharmaceutical or cosmetic sectors, particularly those involved in hair growth products, should be aware of this filing for competitive intelligence and potential licensing or development opportunities.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

FORMULATION FOR STIMULATING HAIR GROWTH AND IMPROVING QUALITY AND METHOD OF PREPARATION OF THE SAME

Application US20260083789A1 Kind: A1 Mar 26, 2026

Assignee

ARJUNA NATURAL PRIVATE LIMITED

Inventors

Benny ANTONY

Abstract

The present invention relates to a formulation for stimulating hair growth and improving quality and the active ingredient derived is from plant sources, especially comprising 10-20% nitrate enriched extract of Amaranth. In addition, said formulation is having one or more ingredients selected from liquid paraffin, mango butter, bees wax, cetyl alcohol, glycerol, sodium benzoate, potassium Sorbate. It also discloses a method of preparation of said formulation, its application as well as its use for stimulating hair growth and improving hair quality. It is found that said formulation has high wound healing potential at lower concentration by Increasing the rate of cell proliferation. It increases not only the Hair growth rate but also increases total hair count and density (n/cm2) of Terminal hair, Vellus hair and Anagen hair. Applying said formulation on the scalp helps in stimulating hair growth and improving the quality of hair.

CPC Classifications

A61K 36/21 A61K 9/0019 A61K 47/06 A61K 47/10 A61K 47/12 A61K 47/22 A61K 47/44 A61P 17/14

Filing Date

2023-09-14

Application No.

19111006

View original document →

Named provisions

FORMULATION FOR STIMULATING HAIR GROWTH AND IMPROVING QUALITY AND METHOD OF PREPARATION OF THE SAME

Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083789A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product Development Cosmetic Formulation
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Product Development Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!